Filter By:

CAR T-cell update: therapy improves outcomes for patients with B-cell lymphoma

An international phase-2 trial of a CAR T-cell therapy found that 52 percent of patients responded favorably.

Perfecting MRI as a breast cancer screening tool
Mapping genetic differences in breast cancer can improve care for underserved populations